Page last updated: 2024-08-23

substance p and Hyperglycemia, Postprandial

substance p has been researched along with Hyperglycemia, Postprandial in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Nam, D; Park, KS; Yu, J1
Choi, S; Jung, N; Kim, D; Lee, SH; Park, KS; Son, Y; Um, J1
Bulc, M; Całka, J; Dąbrowski, M; Palus, K1
Danielson, P; Di, G; Duan, H; Qi, X; Qu, M; Wang, Y; Xie, L; Yang, L; Zhou, Q1
Chen, CH; Hong, YR; Howng, SL; Hsu, KS; Huang, HT; Lai, CL; Lam, HC; Liu, GS; Shi, JY; Shin, SJ; Tai, MH; Wen, ZH1
Guthrie, P; Jain, M; LoGerfo, FW; Pradhan, L1

Other Studies

6 other study(ies) available for substance p and Hyperglycemia, Postprandial

ArticleYear
Substance P enhances cellular migration and inhibits senescence in human dermal fibroblasts under hyperglycemic conditions.
    Biochemical and biophysical research communications, 2020, 02-19, Volume: 522, Issue:4

    Topics: Cell Movement; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Dermis; Fibroblasts; Glucose; Humans; Hyperglycemia; rac1 GTP-Binding Protein; rho-Associated Kinases; src-Family Kinases; Substance P

2020
Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
    Biochemical and biophysical research communications, 2018, 05-23, Volume: 499, Issue:4

    Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hyperglycemia; Immunomodulation; Insulin-Secreting Cells; Male; Mice, Inbred NOD; Pancreatic Stellate Cells; Substance P

2018
Hyperglycaemia-Induced Downregulation in Expression of nNOS Intramural Neurons of the Small Intestine in the Pig.
    International journal of molecular sciences, 2019, Apr-04, Volume: 20, Issue:7

    Topics: Animals; Central Nervous System; Enteric Nervous System; Female; Galanin; Hyperglycemia; Intestine, Small; Neurons; Nitric Oxide Synthase Type I; Substance P; Swine; Vasoactive Intestinal Peptide

2019
Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor.
    Diabetes, 2014, Volume: 63, Issue:12

    Topics: Animals; Cell Line; Cornea; Corneal Injuries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epithelial Cells; ErbB Receptors; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neurotransmitter Agents; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Neurokinin-1; Sirtuin 1; Substance P; Touch; Wound Healing

2014
Peripheral gene transfer of glial cell-derived neurotrophic factor ameliorates neuropathic deficits in diabetic rats.
    Human gene therapy, 2009, Volume: 20, Issue:7

    Topics: Animals; Axons; Calcitonin Gene-Related Peptide; Diabetic Neuropathies; Gene Transfer Techniques; Genetic Therapy; Glial Cell Line-Derived Neurotrophic Factor; Hyperglycemia; Injections, Intramuscular; Myelin Sheath; Rats; Sciatic Nerve; Signal Transduction; Streptozocin; Substance P

2009
Effect of hyperglycemia and neuropeptides on interleukin-8 expression and angiogenesis in dermal microvascular endothelial cells.
    Journal of vascular surgery, 2011, Volume: 53, Issue:6

    Topics: Cell Proliferation; Cells, Cultured; Dermis; Endothelial Cells; Endothelium, Vascular; Humans; Hyperglycemia; Interleukin-8; Microvessels; Neovascularization, Physiologic; Neuropeptide Y; Neuropeptides; Substance P; Wound Healing

2011